NCT03766750View on ClinicalTrials.gov

Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

November 30, 2023

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

LIMA association

1 coated tablet, oral, once a day.

DRUG

Tradjenta

1 coated tablet, oral, once a day.

DRUG

Forxiga

1 coated tablet, oral, once a day.

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT03766750 - Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus. | Biotech Hunter | Biotech Hunter